Fractyl Health, Inc.
GUTS
$1.10
$0.010.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.50% | 4.95% | -7.75% | -34.50% | -418.63% |
| Total Depreciation and Amortization | -6.90% | 30.04% | 6.70% | 8.85% | 262.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,107.92% | -90.30% | -1.66% | 474.39% | 93.75% |
| Change in Net Operating Assets | 269.51% | -138.12% | 132.00% | 324.11% | -128.00% |
| Cash from Operations | 15.47% | -47.23% | 5.57% | 3.73% | -59.99% |
| Capital Expenditure | 78.13% | -92.27% | -9.39% | 18.08% | 75.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 78.13% | -92.27% | -9.39% | 18.08% | 75.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.75% | -2.83% | -82.76% | -176.19% | -950.00% |
| Issuance of Common Stock | 468.57% | 61.85% | -21.36% | 1,275.00% | -99.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 765.50% | 155.22% | -58.64% | 3,340.00% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.84% | -47.42% | 4.92% | 4.80% | -121.54% |